TYERCAN
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
TYERCAN
Industry:
Biotechnology Health Care Medical Pharmaceutical Product Research
Founded:
2017-01-01
Address:
Shenzhen, Guangdong, China
Country:
China
Status:
Active
Similar Organizations
3H Pharmaceuticals
3H Pharmaceuticals focuses on the research and development of macromolecular antibody drugs and innovative small molecules.
Ab&B Biotech
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.
Ascentawits
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs.
Evergreen Therapeutics
Evergreen Therapeutics engages in the research and development of clinical drugs in the field of immunity and ophthalmology.
QureBio
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals.
Stem Bio
Stem Bio is a developer of stem cell therapy and anti-cancer drugs.
Zenova Pharmaceutical
Zenova Pharmaceutical focuses on research and development of new drugs, research, and development pharmaceutical preparations.
Investors List
BIOCHING CAPITAL
BIOCHING CAPITAL investment in Angel Round - Tyercan
More informations about "Tyercan"
Organization - Shenzhen Tyercan Bio-pharm Co., Ltd.
Tel: +86-755-84517304 E-mail: [email protected] Address: No. 901, 9th Floor, Building 10, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi ...See details»
Shenzhen Tyercan Bio-pharm Co., Ltd.
Organization; Partner; Products Tye-1001; Tye-1002; Tye-1014; Tye-1317; Tye-2001; News Company news; Industry news; Recruitment ... Tyercan is a biopharmaceutical company …See details»
深圳市泰尔康生物医药科技有限公司
邮箱: [email protected] . 地址: 深圳市坪山区坑梓街道金辉路14号深圳市生物医药创新产业园区10号楼9层901号. 上海办事处: 上海市徐汇区枫林路420号枫林国际大厦二期A座二楼C16号See details»
Tyercan - Crunchbase Company Profile & Funding
Tyercan is located in Shenzhen, Guangdong, China. Who invested in Tyercan? Tyercan is funded by BIOCHING CAPITAL. When was the last funding round for Tyercan? Tyercan closed its …See details»
Tyercan - Funding, Financials, Valuation & Investors - Crunchbase
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs. Search Crunchbase. Start Free Trial . Chrome Extension. ... How …See details»
Tyercan Company Profile 2024: Valuation, Funding & Investors
Tyercan General Information Description. Developer of a targeted anti-tumor autoimmune drug. The company has developed a variety of innovative targeted drugs by using its platform …See details»
Tyercan - Crunchbase
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.See details»
Shenzhen Tyercan Bio-pharm Co., Ltd. - Drug pipelines, Patents ...
Literatures (Medical) associated with Shenzhen Tyercan Bio-pharm Co., Ltd. ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as …See details»
Company Introduction - Shenzhen Tyercan Bio-pharm Co., Ltd.
Shenzhen Tyercan Bio-pharm Co., Ltd. +86-18123972329 [email protected] Home About us Company Introduction; Industry Background; Development Timeline; Membership; Patent …See details»
Shenzhen Tyercan Bio-pharm Co., Ltd. - synapse.zhihuiya.com
了解Shenzhen Tyercan Bio-pharm Co., Ltd. (深圳市泰尔康生物医药科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的16篇新闻和7篇文献，疾病领域:肿瘤，免疫系统疾病，血液 …See details»
Tyercan - Products, Competitors, Financials, Employees, …
Tyercan is a biopharmaceutical company focused on the development of innovative targeted therapeutics for serious diseases such as malignant tumors, organ transplantation, and …See details»
Industry Background - Shenzhen Tyercan Bio-pharm Co., Ltd.
Shenzhen Tyercan Bio-pharm Co., Ltd. +86-18123972329 [email protected] Home About us Company Introduction; Industry Background; Development Timeline; Membership; Patent …See details»
TYERCAN Trademark Application of SHENZHEN TYERCAN BIO …
Aug 31, 2021 TYERCAN - Trademark Details. Status: 630 - New Application - Record Initialized Not Assigned To Examiner. Serial Number. 97005487. Word Mark. TYERCAN. Status. 630 - …See details»
Tye-2001 - Drug Targets, Indications, Patents - Synapse
Tye-2001, Initially developed by Shenzhen Tyercan Bio-pharm Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune System Diseases, Active Indication: …See details»
Honors - Shenzhen Tyercan Bio-pharm Co., Ltd.
Shenzhen Tyercan Bio-pharm Co., Ltd. +86-18123972329 [email protected] Home About us Company Introduction; Industry Background; Development Timeline; Membership; Patent …See details»
Tyercan was named "The Most Innovative Chinese …
泰尔康医药（Tyercan）是一家由美国杜兰大学药物专家创立的、国际医药专家团队组成的、获得深圳市高层次创新创业团队支持的国家级高新技术企业。公司聚焦于最新药物研发赛道——多 …See details»
Tye-1001 - Drug Targets, Indications, Patents - Synapse - Patsnap
Tye-1001, Initially developed by Shenzhen Tyercan Bio-pharm Co., Ltd., Now, its global highest R&D status is IND Application, Therapeutic Areas: Neoplasms,Immune System …See details»
Company news - Shenzhen Tyercan Bio-pharm Co., Ltd.
Tel: +86-755-84517304 E-mail: [email protected] Address: No. 901, 9th Floor, Building 10, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi ...See details»
Products - Shenzhen Tyercan Bio-pharm Co., Ltd.
Tyercan currently possesses three major innovative technology platforms: Peptide-Drug Conjugates (PDC), Protein-Drug Conjugates, and Peptide Drugs. Notably, the Peptide-Drug …See details»
Everything is connected, will PDC surpass ADC? - tyercan.com
Tel: +86-755-84517304 E-mail: [email protected] Address: No. 901, 9th Floor, Building 10, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi ...See details»